The pharmaceutical industry faces huge pressures with ever-changing FDA legislation, the constant challenge of complying with Goods Distribution Practices, and rapid global economic growth creating demand for affordable and effective products. With The COVID-19 pandemic, economic and political upheaval in Europe and the US, ongoing volatility in the Middle East, Russia and North Korea, and the shadow cast by international terrorism, continued uncertainty seems the only certainty, and change the only constant.
Flexibility, agility and efficiency are key to surviving and thriving and the difference between success and failure is the ability to take control of the future. With so many variables in play as new drugs work their way through regulation and approval, it’s about planning predictable pipelines.
Oliver Wight has worked with some of the world’s best known pharmaceutical and medical businesses, helping them transform their way of working to tackle these challenges through the implementation of Integrated Business Planning (IBP), so they can plan with greater certainty.
IBP provides the strategic perspective you need to plan over a 36-month rolling horizon, allocating critical resources to satisfy customers in the most profitable way. It provides new product visibility and full business integration to effectively manage product introductions resulting in increased customer service levels and growth in sales. This common-sense process allows you to predict and respond positively to changing conditions, in plenty of time, driving results straight to the bottom line.
Here are some companies we have worked with. Click to download a case study
Scenario Planning Trigger Points – Creating an Integrated Response to Scenarios
Getting the Most From Integrated Business Planning
From Disorder to Agility
Integrated Business Planning for High Performance Businesses
Boost Performance - Connect Strategy and Execution through Integrated Business Planning
Business Transformation in Global Organisations - Lessons learned and successes earned
Successful S&OP through Integrated Business Planning
Who Owns Inventory? Stop the Blame Game
Why Annual Planning Should Be a Significant Non-Event
Transitioning from Sales and Operations Planning to Integrated Business Planning
The Day Exuberance Trumped a Proven Process
Sustainable High Performance and Profitability
Highlights from Oliver Wight's third annual conference in 2016.
Highlights from Oliver Wight's 2018 event for healthcare leaders
With the future still full of uncertainty how can British companies plan ahead?
Highlights from Oliver Wight's 2018 conference about the impact of Brexit on businesses and their supply chains.
Highlights from our unique workshop which took place in November 2019, focusing on the future of Integrated Business Planning, known as Enterprise Business Planning.
CPG companies that manufacture branded goods need to tackle fierce competition , increased manufacturing complexity
The chemical industry continues to deal with significant challenges including increasing safety and environmental
As demand accelerates, how can manufacturing companies balance growth, visibility, profitability, cycle
Over 2.14 billion people are now buying online. It’s a worldwide phenomenon; with e-commerce firmly established as the fastest
This group is for executives and thought leaders in the Healthcare industry who want to share best practices and insights, debate key issues, collaborate and build lasting relationships.